Patent 7354929 was granted and assigned to Pfizer on April, 2008 by the United States Patent and Trademark Office.
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein